Atlas Trials

Radiofrequency Ablation Accompanied With Spontaneous Sorafenib in Early to Intermediate Stage HCC

Clinical trial NCT02187081 · UNKNOWN

Trial details

NCT number
NCT02187081
Sponsor
Southwest Hospital, China
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
HCC
Start date
2017-03-15
Primary completion
2018-12-01
Enrollment
380

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.